Swoop Portable MR Imaging System
Hyperfine, Inc. • Radiology • 06/10/2022
Device Purpose
The Swoop® Portable MR Imaging System is a bedside device for imaging the internal structures of the head using magnetic resonance technology, primarily when full diagnostic exams are impractical. It leverages deep learning for image reconstruction to improve image quality in T1W, T2W, and FLAIR sequences, alongside modified pulse sequence options and enhanced noise correction.
Summary
The Swoop® Portable MR Imaging System is a device designed for bedside magnetic resonance imaging, specifically to produce images displaying the internal structure of the head. Its primary application is in situations where conducting a full diagnostic MRI examination is not clinically practical. The system utilizes a 63.3 mT permanent magnet, a single TX/RX head coil, and a gradient system to acquire image data. It supports various imaging sequences, including T1-weighted (T1W), T2-weighted (T2W), Fluid-Attenuated Inversion Recovery (FLAIR), and Diffusion-Weighted Imaging (DWI). A key feature is its image reconstruction algorithm, which employs deep learning techniques to enhance image quality for T1W, T2W, and FLAIR sequences by reducing image noise and blurring. This version of the device also includes modified pulse sequence options and an enhancement to the existing noise correction feature to remove residual line noise. The system is operated via a commercial off-the-shelf tablet, which serves as the main interface for patient data access, exam setup and execution, viewing MRI image data for quality control, and interacting with cloud storage. It is intended for use with adult and pediatric patients (aged 0 years and older) at the point of care in medical facilities, including emergency rooms, critical care units, and hospital or rehabilitation rooms. Non-clinical performance testing, including software verification and validation, image performance evaluation against NEMA and ACR standards, and cybersecurity assessments, was conducted to ensure the device's functionality and image quality.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. How does the image quality and diagnostic accuracy of the Swoop® system, particularly for DWI sequences, compare quantitatively to conventional high-field MRI systems for various neurological conditions?; What is the typical acquisition time for each pulse sequence (T1W, T2W, FLAIR, DWI), and how might these times impact its utility in time-sensitive emergency or critical care scenarios?; What are the specific performance characteristics and limitations of the deep learning image reconstruction algorithm, especially concerning rare pathologies or atypical anatomical variations?; How does the system's noise correction feature, including the enhancement to remove residual line noise, quantitatively improve image signal-to-noise ratio and reduce specific artifacts compared to the predicate device?; What are the practical considerations and challenges associated with deploying and operating the Swoop® system in diverse point-of-care environments, such as emergency rooms versus rehabilitation units, particularly concerning electromagnetic interference or space constraints?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of ML-BOM, SaaSBOM, OBOM detected in AI-generated device summary.
• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.
• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.
• Not detected in AI-generated device summary: SBOM, HBOM, CBOM, VDR/VEX. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly